Athanor Capital, LP Spring Works Therapeutics, Inc. Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$65.1 - $93.59 $1.14 Million - $1.64 Million	-17,489 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.36 - $77.92 $140,292 - $226,045	-2,901 Reduced 14.23%	17,489 $1.27 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $584,781 - $841,250	-16,181 Reduced 44.25%	20,390 $972,000
Q2 2020 Aug 13, 2020	BUY	$22.98 - $48.57 $511,649 - $1.08 Million	22,265 Added 155.63%	36,571 $1.54 Million
Q1 2020 May 14, 2020	SELL	$20.44 - $41.21 $331,250 - $667,849	-16,206 Reduced 53.11%	14,306 $386,000
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $541,282 - $1.21 Million	30,512 New	30,512 $1.17 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.